Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-23-021751

Chief Executive Officer bought 15,021 shares at an average $0.54 ($8,061)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huntsman Ronald Kirk Chief Executive Officer 2023-06-15 Purchase +21 $0.50 $11 57,521 D
Huntsman Ronald Kirk Chief Executive Officer 2023-06-16 Purchase +10,000 $0.54 $5,400 67,521 D
Huntsman Ronald Kirk Chief Executive Officer 2023-06-16 Purchase +5,000 $0.53 $2,650 72,521 D
Open-market purchases · 15,021 sh · avg $0.54 · $8,061
Loading xslF345X04/ownership.xml…